{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T11:06:50Z","timestamp":1790593610714,"version":"4.1.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Normal-tension glaucoma (NTG) is a distinct form of glaucomatous optic neuropathy characterized by progressive retinal ganglion cell (RGC) degeneration and visual field loss despite intraocular pressure (IOP) remaining within the statistically normal range. Although IOP reduction remains the only established disease-modifying strategy, continued disease progression despite adequate IOP control highlights the importance of IOP-independent mechanisms. Increasing evidence implicates vascular dysregulation, mitochondrial dysfunction, oxidative stress, impaired autophagy, neuroinflammation, axonal transport abnormalities, and circadian dysregulation in increased RGC vulnerability. Genetic studies have identified\n                    <jats:italic>OPTN<\/jats:italic>\n                    and\n                    <jats:italic>TBK1<\/jats:italic>\n                    as the most strongly supported NTG-associated susceptibility genes, whereas many other candidate genes, including\n                    <jats:italic>MYOC<\/jats:italic>\n                    ,\n                    <jats:italic>SARM1<\/jats:italic>\n                    ,\n                    <jats:italic>DLK<\/jats:italic>\n                    ,\n                    <jats:italic>BDNF<\/jats:italic>\n                    ,\n                    <jats:italic>NOS3<\/jats:italic>\n                    ,\n                    <jats:italic>KLF2<\/jats:italic>\n                    and\n                    <jats:italic>PTGDS<\/jats:italic>\n                    , are shared with other glaucoma subtypes or remain supported primarily by experimental or mechanistic evidence. These interconnected processes converge on mitochondrial impairment, axonal degeneration, and RGC death, providing potential therapeutic targets beyond conventional IOP lowering. This review integrates the vascular, mitochondrial, and neuronal mechanisms underlying NTG, distinguishes NTG-associated molecular factors from pathways shared across glaucoma subtypes, and summarizes emerging gene- and nucleic-acid-based therapeutic strategies. By linking evidence-based mechanisms with emerging molecular technologies, this review provides a framework for mechanism-based and precision-oriented therapies that may complement established IOP-lowering treatment for NTG.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1950490","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:53:44Z","timestamp":1790592824000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic susceptibility and neuroprotective gene therapy of normal tension glaucoma: a review"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoyu","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The Second People\u2019s Hospital Affiliated to China Three Gorges University, Yichang Second People\u2019s Hospital","place":["Yichang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dadong","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second People\u2019s Hospital Affiliated to China Three Gorges University, Yichang Second People\u2019s Hospital","place":["Yichang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second People\u2019s Hospital Affiliated to China Three Gorges University, Yichang Second People\u2019s Hospital","place":["Yichang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The Second People\u2019s Hospital Affiliated to China Three Gorges University, Yichang Second People\u2019s Hospital","place":["Yichang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4103\/1673-5374.293145","article-title":"Dysfunction of axonal transport in normal-tension glaucoma: a biomarker of disease progression and a potential therapeutic target","volume":"16","author":"Hirooka","year":"2021","journal-title":"Neural Regen Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/1673-5374.344831","article-title":"Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies","volume":"18","author":"Shen","year":"2023","journal-title":"Neural Regen Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41433-018-0042-2","article-title":"Normal tension glaucoma: review of current understanding and mechanisms of the pathogenesis","volume":"32","author":"Killer","year":"2018","journal-title":"Eye (Lond)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.survophthal.2018.07.003","article-title":"Managing normal tension glaucoma by lowering the intraocular pressure","volume":"64","author":"Razeghinejad","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s10103-025-04372-4","article-title":"Intraocular pressure-lowering effects of selective laser trabeculoplasty for normal tension glaucoma patients in Chinese","volume":"40","author":"Xuejiao","year":"2025","journal-title":"Lasers Med Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/ceo.14408","article-title":"Angle-based minimally invasive glaucoma surgery in normal tension glaucoma: a systematic review and meta-analysis","volume":"52","author":"Oo","year":"2024","journal-title":"Clin Exp Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"101191","DOI":"10.1016\/j.preteyeres.2023.101191","article-title":"Familial normal tension glaucoma genetics","volume":"96","author":"Fox","year":"2023","journal-title":"Prog Retin Eye Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4330\/wjc.v16.i1.10","article-title":"Unveiling the silent link: normal-tension glaucoma\u2019s enigmatic bond with cardiac blood flow","volume":"16","author":"Ramesh","year":"2024","journal-title":"World J Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e110693","DOI":"10.7759\/cureus.110693","article-title":"Primary vascular dysregulation in normal-tension glaucoma: pathophysiology and management","volume":"18","author":"Banerjee","year":"2026","journal-title":"Cureus"},{"key":"B10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.31083\/j.fbl2912410","article-title":"Circadian disruption in glaucoma: causes, consequences, and countermeasures","volume":"29","author":"Gubin","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1097\/ijg.0000000000000751","article-title":"The relation between endothelial nitric oxide synthase polymorphisms and normal tension glaucoma","volume":"26","author":"Jeoung","year":"2017","journal-title":"J Glaucoma"},{"key":"B12","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/eye.2014.42","article-title":"Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma","volume":"28","author":"Kang","year":"2014","journal-title":"Eye (Lond)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/ceo.14043","article-title":"Normal-tension glaucoma: current concepts and approaches-A review","volume":"50","author":"Leung","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"B14","first-page":"1016","article-title":"Investigations on the association between normal tension glaucoma and single nucleotide polymorphisms of the endothelin-1 and endothelin receptor genes","volume":"12","author":"Kim","year":"2006","journal-title":"Mol Vis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/iovs.67.2.21","article-title":"Integrative proteogenomic analysis identifies genetically supported plasma proteins, metabolites, and pathways in glaucoma","volume":"67","author":"Yuan","year":"2026","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.survophthal.2021.09.001","article-title":"Juvenile-onset open-angle glaucoma\u2014a clinical and genetic update","volume":"67","author":"Selvan","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/antiox10020238","article-title":"Oxidative stress and the role of NADPH oxidase in glaucoma","volume":"10","author":"Fan Gaskin","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/jnr.24042","article-title":"Mitochondrial biogenesis in neurodegeneration","volume":"95","author":"Li","year":"2017","journal-title":"J Neurosci Res"},{"key":"B19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13024-018-0287-z","article-title":"Essential roles of mitochondrial biogenesis regulator Nrf1 in retinal development and homeostasis","volume":"13","author":"Kiyama","year":"2018","journal-title":"Mol Neurodegener"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.3390\/cells11142203","article-title":"Differential susceptibility of retinal neurons to the loss of mitochondrial biogenesis factor Nrf1","volume":"11","author":"Kiyama","year":"2022","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/iovs.64.10.1","article-title":"TBK1 knockdown alleviates axonal transport deficits in retinal ganglion cells via mTORC1 activation in a retinal damage mouse model","volume":"64","author":"Ye","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/15548627.2021.1888244","article-title":"Regulation of PRKN-independent mitophagy","volume":"18","author":"Tere\u0161ak","year":"2022","journal-title":"Autophagy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.7150\/ijbs.25996","article-title":"The Nrf2 signaling in retinal ganglion cells under oxidative stress in ocular neurodegenerative diseases","volume":"14","author":"Liu","year":"2018","journal-title":"Int J Biol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8060962","DOI":"10.1155\/2019\/8060962","article-title":"Inhibition of cAMP\/PKA pathway protects optic nerve head astrocytes against oxidative stress by akt\/bax phosphorylation-mediated Mfn1\/2 oligomerization","volume":"2019","author":"Ju","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3390\/ph17101261","article-title":"Advances in neuroprotection in glaucoma: pharmacological strategies and emerging technologies","volume":"17","author":"Wang","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/antiox9090874","article-title":"Suppression of oxidative stress as potential therapeutic approach for normal tension glaucoma","volume":"9","author":"Harada","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41418-024-01390-7","article-title":"RIP1 inhibition protects retinal ganglion cells in glaucoma models of ocular injury","volume":"32","author":"Kim","year":"2025","journal-title":"Cell Death Differ"},{"key":"B28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s40478-024-01872-2","article-title":"Acquisition of neurodegenerative features in isogenic OPTN(E50\u2005K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction","volume":"12","author":"Huang","year":"2024","journal-title":"Acta Neuropathol Commun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0156001","DOI":"10.1371\/journal.pone.0156001","article-title":"SQSTM1 mutations and glaucoma","volume":"11","author":"Scheetz","year":"2016","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41419-023-06140-0","article-title":"Inhibition of cGAS-STING pathway alleviates neuroinflammation-induced retinal ganglion cell death after ischemia\/reperfusion injury","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e68148","DOI":"10.7554\/eLife.68148","article-title":"Quantitative transportomics identifies Kif5a as a major regulator of neurodegeneration","volume":"11","author":"Shah","year":"2022","journal-title":"Elife"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1167\/iovs.64.3.4","article-title":"Kif5a regulates mitochondrial transport in developing retinal ganglion cells in vitro","volume":"64","author":"Yokota","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/febs.16739","article-title":"A glaucoma-associated OPTN polymorphism, M98\u2005K sensitizes retinal cells to endoplasmic reticulum stress and tumour necrosis factor \u03b1","volume":"290","author":"Sayyad","year":"2023","journal-title":"Febs j"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3389\/fimmu.2018.01287","article-title":"Altered functions and interactions of glaucoma-associated mutants of optineurin","volume":"9","author":"Swarup","year":"2018","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/tvst.15.5.2","article-title":"Targeting circadian rhythm disruption in glaucoma: pTGDS mediates trabecular meshwork fibrosis and is therapeutically targeted by aprepitant","volume":"15","author":"Yuan","year":"2026","journal-title":"Transl Vis Sci Technol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/bjophthalmol-2018-313381","article-title":"Exogenous influences on intraocular pressure","volume":"103","author":"Kim","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2025.13726","article-title":"Retinal light perception and biological rhythms: the role of light in sleep and mood from an ophthalmic perspective (review)","volume":"33","author":"Yuan","year":"2026","journal-title":"Mol Med Rep"},{"key":"B38","doi-asserted-by":"publisher","first-page":"111229","DOI":"10.1016\/j.exer.2026.111229","article-title":"Intrinsically photosensitive retinal ganglion cell dysfunction and suprachiasmatic nucleus -mediated circadian disruption in humans: a systematic review","volume":"272","author":"Dhinesh","year":"2026","journal-title":"Exp Eye Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajo.2025.08.019","article-title":"Sleep disturbance as a risk factor for retinal neurodegeneration and subsequent glaucoma","volume":"280","author":"AKADA","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"502549","DOI":"10.1016\/j.oftale.2026.502549","article-title":"Melatonin and glaucoma: current insights and clinical prospectives","volume":"101","author":"Martucci","year":"2026","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/s41433-025-03638-z","article-title":"Association between normal tension glaucoma and the risk of obstructive sleep apnoea using the STOP-bang questionnaire","volume":"39","author":"Koh","year":"2025","journal-title":"Eye (Lond)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41434-019-0105-4","article-title":"Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics","volume":"27","author":"Rodriguez-Estevez","year":"2020","journal-title":"Gene Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/1673-5374.375319","article-title":"The concept of gene therapy for glaucoma: the dream that has not come true yet","volume":"19","author":"Sulak","year":"2024","journal-title":"Neural Regen Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1038\/s41467-025-57135-8","article-title":"Optineurin-facilitated axonal mitochondria delivery promotes neuroprotection and axon regeneration","volume":"16","author":"Liu","year":"2025","journal-title":"Nat Commun"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.ymthe.2022.01.035","article-title":"NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function","volume":"30","author":"Fang","year":"2022","journal-title":"Mol Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12974-016-0499-5","article-title":"Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress","volume":"13","author":"Hines-Beard","year":"2016","journal-title":"J Neuroinflammation"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.ymthe.2024.04.030","article-title":"Sirt6 protects retinal ganglion cells and optic nerve from degeneration during aging and glaucoma","volume":"32","author":"Xia","year":"2024","journal-title":"Mol Ther"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1586240","DOI":"10.3389\/fcell.2025.1586240","article-title":"Caspase-mediated pathways in retinal ganglion cell injury: a novel therapeutic target for glaucoma","volume":"13","author":"Rajakrishna","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"Jama"},{"key":"B50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/mt.2013.216","article-title":"In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma","volume":"22","author":"Mart\u00ednez","year":"2014","journal-title":"Mol Ther"},{"key":"B51","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.7150\/thno.55472","article-title":"Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner","volume":"11","author":"Abbasi","year":"2021","journal-title":"Theranostics"},{"key":"B52","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41419-018-0780-x","article-title":"Nogo-A inactivation improves visual plasticity and recovery after retinal injury","volume":"9","author":"Mdzomba","year":"2018","journal-title":"Cell Death Dis"},{"key":"B53","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1186\/s12967-022-03747-3","article-title":"Current strategies employed in the manipulation of gene expression for clinical purposes","volume":"20","author":"Tsai","year":"2022","journal-title":"J Transl Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cellsig.2018.11.006","article-title":"Neuroprotective effects of overexpressed microRNA-200a on activation of glaucoma-related retinal glial cells and apoptosis of ganglion cells via downregulating FGF7-mediated MAPK signaling pathway","volume":"54","author":"Peng","year":"2019","journal-title":"Cell Signal"},{"key":"B55","doi-asserted-by":"publisher","first-page":"100849","DOI":"10.1016\/j.preteyeres.2020.100849","article-title":"Extracellular vesicle therapy for retinal diseases","volume":"79","author":"Mead","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"516","DOI":"10.4103\/1673-5374.320974","article-title":"The role of miRNA in retinal ganglion cell health and disease","volume":"17","author":"Mead","year":"2022","journal-title":"Neural Regen Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"653522","DOI":"10.3389\/fcell.2021.653522","article-title":"The role of MicroRNAs in mitochondria-mediated eye diseases","volume":"9","author":"Carrella","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.3390\/ijms22052421","article-title":"Crosstalk between MicroRNA and oxidative stress in primary open-angle glaucoma","volume":"22","author":"Tabak","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/biom11040581","article-title":"Use of gene therapy in retinal ganglion cell neuroprotection: current concepts and future directions","volume":"11","author":"Rhee","year":"2021","journal-title":"Biomolecules"},{"key":"B60","doi-asserted-by":"publisher","first-page":"101614","DOI":"10.1016\/j.omtm.2025.101614","article-title":"Therapeutic mRNA delivery of CRISPR-Cas9 to the trabecular meshwork reverses ocular hypertension in myocilin glaucoma","volume":"33","author":"Yacoub","year":"2025","journal-title":"Mol Ther Methods Clin Dev"},{"key":"B61","doi-asserted-by":"publisher","first-page":"107638","DOI":"10.1016\/j.phrs.2025.107638","article-title":"From bench to bedside: developing CRISPR\/cas-based therapy for ocular diseases","volume":"213","author":"Zhao","year":"2025","journal-title":"Pharmacol Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41433-022-02169-1","article-title":"The application and progression of CRISPR\/Cas9 technology in ophthalmological diseases","volume":"37","author":"Hu","year":"2023","journal-title":"Eye (Lond)"},{"key":"B63","doi-asserted-by":"publisher","first-page":"100834","DOI":"10.1016\/j.curtheres.2026.100834","article-title":"Aptamers in ocular disease therapy and drug delivery: current progress and future opportunities","volume":"105","author":"Dur\u00e1n-Cristiano","year":"2026","journal-title":"Curr Ther Res Clin Exp"},{"key":"B64","doi-asserted-by":"publisher","first-page":"101852","DOI":"10.1016\/j.bbrep.2024.101852","article-title":"Recent advances in aptamer discovery, modification and improving performance","volume":"40","author":"Fallah","year":"2024","journal-title":"Biochem Biophys Rep"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4806","DOI":"10.1021\/acsbiomaterials.5c00504","article-title":"Enhanced glioblastoma-targeted aptamer discovery by 3D cell-SELEX with hyaluronic acid hydrogel","volume":"11","author":"Kim","year":"2025","journal-title":"ACS Biomater Sci Eng"},{"key":"B66","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2174\/1566523221666210126152000","article-title":"Gene therapy strategies for glaucomatous neurodegeneration","volume":"21","author":"Lani-Louzada","year":"2021","journal-title":"Curr Gene Ther"},{"key":"B67","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1038\/s41467-024-50354-5","article-title":"NMNAT2 is a druggable target to drive neuronal NAD production","volume":"15","author":"Tribble","year":"2024","journal-title":"Nat Commun"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1950490\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T10:53:45Z","timestamp":1790592825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1950490\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":67,"alternative-id":["10.3389\/fmed.2026.1950490"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1950490","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1950490"}}